Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jan. 30, 2021
Summary of Significant Accounting Policies [Abstract]  
Reconciliation of cash and restricted cash equivalents [Table Text Block] The following table provides a reconciliation of cash and restricted cash equivalents reported with the consolidated balance sheets to the total of the same amounts shown in the consolidated statements of cash flows:

    

January 30,2021

    

February 1,2020

 

February 2, 2019

Cash

$

15,485,000

$

10,287,000

$

20,485,000

Restricted cash equivalents

 

 

 

450,000

Total cash and restricted cash equivalents

$

15,485,000

$

10,287,000

$

20,935,000

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

A reconciliation of net loss per share calculations and the number of shares used in the calculation of basic net loss per share and diluted net loss per share is as follows:

    

For the Years Ended

January 30, 2021

    

February 1, 2020

    

February 2, 2019

Numerator:

 

  

 

  

 

  

Net loss

$

(13,234,000)

$

(56,296,000)

$

(22,157,000)

Earnings allocated to participating share awards (a)

 

 

 

Net loss attributable to common shares — Basic and diluted

$

(13,234,000)

$

(56,296,000)

$

(22,157,000)

Denominator:

 

  

 

  

 

  

Weighted average number of common shares outstanding — Basic (b)

 

10,745,916

 

7,462,380

 

6,607,321

Dilutive effect of stock options, non-vested shares and warrants (c)

 

 

 

Weighted average number of common shares outstanding — Diluted

 

10,745,916

 

7,462,380

 

6,607,321

Net loss per common share

$

(1.23)

$

(7.54)

$

(3.35)

Net loss per common share — assuming dilution

$

(1.23)

$

(7.54)

$

(3.35)

(a) During fiscal 2018, the Company issued a restricted stock award that is a participating security. For fiscal 2020, fiscal 2019 and fiscal 2018, the entire undistributed loss is allocated to common shareholders.
(b) For fiscal 2020, the basic earnings per share computation included 21,000 outstanding fully-paid warrants to purchase shares of the Company’s common stock at a price of $0.001 per share.
(c) For fiscal 2020, fiscal 2019 and fiscal 2018, there were 591,000, 46,000 and 34,000 incremental, in-the-money, potentially dilutive common shares outstanding. The incremental in-the-money potentially dilutive common stock shares are excluded from the computation of diluted earnings per share, as the effect of their inclusion would be anti-dilutive.